|
1
|
de la Cruz-Merino L, Grande-Pulido E,
Albero-Tamarit A and Codes-Manuel de Villena ME: Cancer and immune
response: Old and new evidence for future challenges. Oncologis.
13:1246–1254. 2008. View Article : Google Scholar
|
|
2
|
Gooden MJ, de Bock GH, Leffers N, Daemen T
and Nijman HW: The prognostic influence of tumour-infiltrating
lymphocytes in cancer: A ystematic review with meta-analysis. Br J
Cancer. 105:93–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delyon J, Mateus C, Lefeuvre D, Lanoy E,
Zitvogel L, Chaput N, Roy S, Eggermont AM, Routier E and Robert C:
Experience in daily practice with ipilimumab for the treatment of
patients with metastaticmelanoma: An early increase in lymphocyte
and eosinophil counts is associated with improved survival. Ann
Oncol. 24:1697–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee AH, Gillett CE, Ryder K, Fentiman IS,
Miles DW and Millis RR: Different patterns of inflammation and
prognosis in invasive carcinoma of the breast. Histopathology.
48:692–701. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lipson EJ, Sharfman WH, Drake CG, Wollner
I, Taube JM, Anders RA, Xu H, Yao S, Pons A, Chen L, et al: Durable
cancer regression off-treatment and effective reinduction therapy
with an anti-PD-1 antibody. Clin Cancer Res. 19:462–468. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ,
Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, et al:
Safety and activity of anti-PD-L1 antibody in patients with
advanced cancer. N Engl J Med. 366:2455–2465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pichler R, Fritz J, Zavadil C, Schäfer G,
Culig Z and Brunner A: Tumor-infiltrating immune cell
subpopulations influence the oncologic outcome after intravesical
Bacillus Calmette-Guérin therapy in bladder cancer. Oncotarget.
7:39916–39930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis MM and Bjorkman PJ: T cell antigen
receptor genes and T cell recognition. Nature. 334:395–402. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rubtsova K, Scott-Browne JP, Crawford F,
Dai S, Marrack P and Kappler JW: Many different Vbeta CDR3s can
reveal the inherent MHC reactivity of germline-encoded TCR V
regions. Proc Natl Acad Sci USA. 106:7951–7956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arstila TP, Casrouge A, Baron V, Even J,
Kanellopoulos J and Kourilsky P: A direct estimate of the human
alphabeta T cell receptor diversity. Science. 286:958–961. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serratì S, De Summa S, Pilato B, Petriella
D, Lacalamita R, Tommasi S and Pinto R; Next-generation sequencing,
: Advances and applications in cancer diagnosis. Onco Targets Ther.
9:7355–7365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calis JJ and Rosenberg BR: Characterizing
immune repertoires by high throughput sequencing: Strategies and
applications. Trends Immunol. 35:581–590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gerlinger M, Quezada SA, Peggs KS, Furness
AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ,
Hazell S, et al: Ultra-deep T cell receptor sequencing reveals the
complexity and intratumour heterogeneity of T cell clones in renal
cell carcinomas. J Pathol. 231:424–432. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weng WK, Armstrong R, Arai S, Desmarais C,
Hoppe R and Kim YH: Minimal residual disease monitoring with
high-throughput sequencing of T cell receptors in cutaneous T cell
lymphoma. Sci Transl Med. 5:214ra1712013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakanishi K, Kukita Y, Segawa H, Inoue N,
Ohue M and Kato K: Characterization of the T cell receptor beta
chain repertoire in tumor-infiltrating lymphocytes. Cancer Med.
5:2513–2521. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lefranc MP: Immunoglobulin and T cell
receptor genes: IMGT(®) and the birth and rise of
immunoinformatics. Front Immunol. 5:222014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hou X, Lu C, Chen S, Xie Q, Cui G, Chen J,
Chen Z, Wu Z, Ding Y, Ye P, et al: High throughput sequencing of T
cell antigen receptors reveals a conserved TCR repertoire. Medicine
(Baltimore). 95:e28392016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui W, Hou X, Zou G, Che W, Yang M, Zheng
C, Liu F, Chen P, Wei X, Lai L and Dai Y: Composition and variation
analysis of the TCR β-chain CDR3 repertoire in systemic lupus
erythematosus using high-throughput sequencing. Mol Immunol.
67:455–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lipponen PK, Eskelinen MJ, Jauhiainen K,
Harju E and Terho R: Tumour infiltrating lymphocytes as an
independent prognostic factor in transitional cell bladder cancer.
Eur J Cancer 29A. 69–75. 1992.
|
|
20
|
Magurran AE: Measuring biological
diversity. John Wiley & Sons; 2013
|
|
21
|
Han Y, Liu X, Wang Y, Wu X, Guan Y, Li H,
Chen X, Zhou B, Yuan Q, Ou Y, et al: Identification of
characteristic TRB V usage in HBV-associated HCC by using
differential expression profiling analysis. OncoImmunology.
4:e10215372015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Velotti F, Chopin D, Gil-Diez S, Maille P,
Abbou CC, Kourilsky P and Even J: Clonality of tumor-infiltrating
lymphocytes in human urinary bladder carcinoma. J Immunother.
20:470–478. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Long SA, Khalili J, Ashe J, Berenson R,
Ferrand C and Bonyhadi M: Standardized analysis for the
quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol
Methods. 317:100–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miqueu P, Guillet M, Degauque N, Doré JC,
Soulillou JP and Brouard S: Statistical analysis of CDR3 length
distributions for the assessment of T and B cell repertoire biases.
Mol Immunol. 44:1057–1064. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang T, Wang C, Wu J, He C, Zhang W, Liu
J, Zhang R, Lv Y, Li Y, Zeng X, et al: The different T cell
receptor repertoires in breast cancer tumors, draining lymph nodes,
and adjacent tissues. Cancer Immunol Res. 5:148–156. 2017.
View Article : Google Scholar : PubMed/NCBI
|
